==== Front Int Ophthalmol Int Ophthalmol International Ophthalmology 0165-5701 1573-2630 Springer Netherlands Dordrecht 36864123 2643 10.1007/s10792-023-02643-z Original Paper Self-reported glaucoma prevalence and related factors, contribution to reported visual impairment, and functional burden in a cross-sectional study in Colombia http://orcid.org/0000-0002-8229-2611 Castellanos-Perilla Nicolás nicolascastellanos@javeriana.edu.co 123 Garcia-Cifuentes Elkin 34 Pineda-Ortega Juliana 3 Lema Sofia 1 Gelvis Geronimo 3 Cano-Gutierrez Carlos Alberto 35 Mejia-Vergara Alvaro J. 6789 1 grid.412835.9 0000 0004 0627 2891 Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway 2 grid.7914.b 0000 0004 1936 7443 Department of Clinical Medicine, University of Bergen, Bergen, Norway 3 grid.41312.35 0000 0001 1033 6040 Semillero de Neurociencias y Envejecimiento, Ageing Institute, Medical School, Pontificia Universidad Javeriana, Bogotá, Colombia 4 grid.448769.0 0000 0004 0370 0846 Neurology Department, Hospital Universitario San Ignacio, Bogotá, Colombia 5 grid.448769.0 0000 0004 0370 0846 Geriatrics Unit, Hospital Universitario San Ignacio, Bogotá, Colombia 6 Department of Ophthalmology, Stein and Doheny Eye Institutes, University of California, Pasadena, Los Angeles, CA USA 7 grid.41312.35 0000 0001 1033 6040 Ophthalmology Department, San Ignacio University Hospital, Pontificia Universidad Javeriana School of Medicine, Bogotá, Colombia 8 grid.442116.4 0000 0004 0404 9258 School of Medicine, Ophthalmology Program, Fundación Universitaria Sanitas, Bogotá, Colombia 9 grid.442116.4 0000 0004 0404 9258 Oftalmosanitas Eye Institute, Fundación Universitaria Sanitas, Bogotá, Colombia 2 3 2023 2 3 2023 2023 43 7 24472455 4 1 2022 19 1 2023 © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Purpose Describe the self-reported prevalence of glaucoma in Colombian older adults, emphasizing the most important risk factors and associated daily-life functional alterations. Methods This a secondary analysis of the Health, Wellness, and Aging survey conducted in the year 2015. Diagnosis of glaucoma was obtained from self-report. Functional variables were assessed through activities of daily living questionnaires. A descriptive analysis followed by bivariate and multivariate regression models adjusting for confounding variables was conducted. Results Self-reported prevalence of glaucoma was 5.67%, with higher rate in women, OR 1.22 (1.13–1.40) p = .003, older age OR 1.02 (1.01–1.02) p < .001, and with higher education OR 1.38 (1.28–1.50) p < .001. Glaucoma was independently associated with diabetes OR 1.37 (1.18–1.61) p  < .001 and hypertension 1.26 (1.08–1.46) p = .003. It also showed statistically significant correlations with poor SRH OR 1.15 (1.02–1.32) p < .001, self-reported visual impairment 1.73 (1.50–2.01) p < .001, and impairment in money management OR 1.59 (1.16–2.08) p  = .002, grocery shopping OR 1.57 (1.26–1.96) p < .001 and preparing meals OR 1.31 (1.06–1.63) p  = .013 and having had falls during the last year OR 1.14 (1.01–1.31) p = 0.041. Conclusion Our findings suggest the self-reported prevalence of glaucoma in older adults in Colombia to be higher than reported data. Glaucoma and visual impairment in older adults represent a public health concern, since glaucoma was associated with adverse outcomes like functional loss and risk of falling, affecting the quality of life and their participation in society. Keywords Glaucoma Aged Functionality Fall Quality of life University of Stavanger & Stavanger University HospitalOpen access funding provided by University of Stavanger & Stavanger University Hospital issue-copyright-statement© Springer Nature B.V. 2023 ==== Body pmcIntroduction Demographic transition is a worldwide phenomenon, due to a decrease in birth rates followed by a decrease in death rates. This transition is a relevant phenomenon in developing countries, increasing the number of people living with chronic illness [1]. The World Health Organization’s (WHO) Integrated Care for Older People tool package states that the visual capacity in older adults is one of the intrinsic domains to preserve [2]. Low vision is defined as visual acuity between 20/50 and 20/200 (Log Mar 0.4 to 0.9), or a visual field remanent of 20°central vision. Legal blindness is defined as visual acuity of less than 20/200 or worse, or a visual field remanent of 10° of central vision [3]. Both definitions based on the better eye with the best possible correction. Visual impairment (VI) encompasses both low vision and legal blindness [3]. In 2015, an estimated 118 million had VI in Latin America and the Caribbean; hence, it is considered a public health priority [2, 4, 5]. Although VI prevalence has declined in the past decades, older adults show a significant increase in VI with age [6–8]. VI in older adults affects quality of life (QoL), increases risk of falls and isolation with lower self-rated health (SRH) [9, 10]. VI is an independent and significant predictor of morbidity, mortality, quality of life, physical and psychological health in older adults [11]. Glaucoma is a progressive optic neuropathy characterized by specific morphological changes in the optic nerve head and nerve fibre layer of the retina [12, 13]. Glaucoma is one of the leading causes of blindness worldwide [10, 12]. Risk factors include intraocular pressure, age over 60, African or Hispanic origin, and family history. One of its major challenges is early diagnosis; half of people with glaucoma are undiagnosed in developed countries [14, 15]. The relationship between age and glaucoma has been extensively studied, with an increase in glaucoma incidence as populations live longer [16]. Aging of the trabecular meshwork leads to increased resistance and secondary aqueous humour flow reduction, and increased intraocular tension, mechanical stress in an aged lamina cribrosa, generates a pressure gradient that distorts axoplasmic transport of retinal ganglion cells [12, 17, 18]. Age may also play a role in neuroinflammation balance and in retinal environment [19]. The global prevalence of glaucoma has been estimated at 3.54%, and in Latin America at 4.51% [20]. Glaucoma contributes to around 8% of the reported blindness being the second cause of blindness in Latin America [5, 21, 22]. In Colombia, the age group with higher rates of glaucoma is those 80 and over with 1.1% estimated prevalence, followed by those 75–79 years with 1.02% [23]. Based on the need to establish the impact of glaucoma and the associated factors in older adults in Colombia, we aimed to describe its self-reported prevalence and analyse its impact in daily activities. We also explored known risk factors. For this we used data from the Health, Wellness and Aging survey 2015 survey, SABE. Materials and methods Study design This study is a secondary analysis from the 2015 SABE study; the SABE study (from its initials in Spanish: Salud, Bienestar and Envejecimiento) comprised 23,694 older adults, non-institutionalized adults aged 60 years and older. Initially conducted by the Pan-American Health Organization (PAHO) and conducted in Colombia in 2015 with a multistage area probability sampling design, supported by a fund from Colombian Science Ministry and the Colombian Ministry of Health and Social Protection Data collection was carried between April and September 2015 with 62% urban and 77% rural response rates [24]. Variables Most variables were obtained through self-report. The dependent variable was the self-report of history of glaucoma (assessed with the question: “Has a doctor ever told you to require treatment for glaucoma?”, Yes/No). Vision impairment was evaluated by self-report as well (with the question “How would you describe your vision? Possible answers included: Very good, good, poor, bad and very bad; we dichotomized answers into bad (very bad, bad, and poor) and good (good–very good)). The questions addressing performance on instrumental activities of daily living (IADL) and need of help were evaluated for the VI report. These questions have been detailed in the survey’s complete method [24]. Confounding variables We included the sociodemographic factors: sex, age, educational level measured with years of schooling, and cognitive decline evaluated with the Mini-Mental State Examination (a score < 24 was the cutoff value for defining cognitive impairment). We included multi-morbidity, defined as reporting ≥ 2 chronic diseases including hypertension (HTN), diabetes (DM), chronic obstructive pulmonary disease (COPD), stroke, myocardial infarction, arthritis/osteoporosis, and cancer. Exclusion criteria We excluded participants who did not answer the questions regarding visual heath. (Fig. 1) Individuals were considered unable to complete the study procedures and excluded at the beginning of the interview if they had a total score of < 13 in the Mini-Mental State Examination (MMSE), and a proxy interview was developed.Fig. 1 Exclusion criteria applied on SABE Colombia study Statistical analysis A descriptive analysis was done using relative and absolute frequencies for nominal variables, and median and interquartile range (IQR) were used for continuous variables. A Shapiro–Wilk test was used for testing normality. For the bivariate analysis, statistical significance was assessed using the chi-squared test for categorical variables and the ANOVA tests for continuous variables. Logistic regression models were fitted to obtain odds ratios (OR) with 95% confidence intervals (CI). An additional linear regression model was built adjusting for the confounding variables. Statistical significance level was set at p < 0.05. Data were analysed using STATA 16 (Stata Corp. LLC Texas, USA). Results The total surveyed sample was 23,694 individuals. We excluded 4782 subjects (17%) based on the exclusion criteria. (Fig. 1). Out of the 18,912, 5.67% had glaucoma. The majority were female in both groups, with a higher proportion in the glaucoma group 62.03% vs 55.71% (p < 0.001). Median age was 71 years (SD ± 8.26) in the glaucoma group vs 69.0 years (SD ± 8.15) in the no-glaucoma group (p < 0.001). Mean education years were 4 years in the glaucoma group vs3 years in people without glaucoma (p < 0.001). In the glaucoma group, 26.8% had DM diagnosis and 65.73% HTN vs v 15.78% (p < 0.001) and 51.30% (p < 0.001) in the no-glaucoma group. Multi-morbidity proportion was more prevalent in the subjects with glaucoma when compared to those without, 58.86% vs 39.20% (p < 0.001). (Table 1).Table 1 Bivariate analysis Glaucoma Yes No n = 1072 (5.67%) n = 17,840 (94.33%) p Median (IQR)X Age 71 (± 8.26) 69 (± 8.15)  < 001 Years in school 5 IQR (5) 3 IQR (4)  < .001 n (%) Females 665 (62.03) 9939 (55.71)  < .001 Diabetes 287 (26.8) 2805 (15.78)  < .001 Hypertension 704 (65.73) 9140 (51.30)  < .001 Poor self-rated health 628 (58.64) 9192 (51.53)  < .001 Multi-morbidity 631 (58.86) 6994 (39.20)  < .001 Vision impairment 826 (77.05) 11,565 (64.83)  < .001 Cognitive decline 108 (10.6) 2286 (12.81) .324 Fear of falling 903 (84.39) 14,250 (80.02)  < .001 Falls in the previous year 379 (35.35) 5231 (29.22)  < .001 Difficulty for IADL 300 (27.99) 4748 (26.61) .321 Difficulty managing money 54 (5.04) 479 (2.68)  < .001 Difficulty shopping for groceries 108 (10.07) 942 (5.28)  < .001 Difficulty preparing meals 111 (10.35) 1341 (7.52)  < .001 Difficulty taking transportation 164 (15.30) 2142 (12.01)  < .001 Difficulty using the telephone 164 (15.30) 2142 (12.01)  < .001 Does not read 250 (26.12) 3747 (25.33) .585 Does not write 657 (68.72) 10,265 (69.45) .638 Difficulty taking medications 71 (6.62) 1023 (5.73) .226 Depressive symptoms 372 (34.70) 6520 (36.55) .223 SD standard deviation, IQR interquartile range, IADL instrumental activities of daily living The self-reported VI rate was higher in the group with glaucoma with of 77.05% compared to 64.83% (p < 0.001) in the group without glaucoma. We found a significant difference between the group with and the one without glaucoma in fear of falling 84.39% vs 80.02% (p < 0.001). (Table 1). Having had falls in the previous year was more frequently reported in the glaucoma group, when compared to the non-glaucoma group. 35.35% vs 29.22% (p < 0.001) poor SRH 58.64 vs 51.52% (p < 0.001) was also more frequently reported in that group. Analysing impairment in IADL, we found difficulties in the following: managing money 5.04% (glaucoma) vs 2.68% (without glaucoma) (p < 0.001), shopping for groceries 10.07% (glaucoma) vs 5.28% (without glaucoma) (p < 0.001), cooking 10.35% vs 7,52% (p < 0.001), use of transportation 15.30% vs 12.01% (p < 0.001), and using the telephone 15.30% vs 12.01% (p < 0.001). (Table 1). The multivariate analysis shows the following variables were independently associated with the self-report of glaucoma, after adjusting for confounding variables (Figs. 2 and 3): female sex OR 1.22 (1.13–1.40) p = 0.003 older age OR 1.02 (CI 1.01–1.02), p < 0.001, higher school level OR 1.36 (CI 1.28–1.50), p < 0.001, DM OR 1.37 (CI 1.18–1.61), p < 0.001, HTN OR 1.26 (CI 1.08–1.46), p < 0.003, and multi-morbidity OR 2.08 (CI 1.83–2.37), p < 0.001. (Table 2).Fig. 2 Multivariate analysis of Glaucoma and related risk factors. OR odds ratio (x axis). (95%CI). Adjusted by confounding factors Fig. 3 Multivariate analysis of Glaucoma and adverse outcomes. OR odds ratio (x axis). (95%CI). Adjusted by confounding factors Table 2 Multivariate analysis OR (SD) p Adjusted OR p Age 1.02 (1.01–1.02)  < .001 1.02 (1.01–1.02)  < .001 Years in school 1.36 (1.26–1.46)  < .001 1,06 (1.05–1.07)  < .001 Females 1.26 (1.13–1.42)  < .001 1.22 (1.13–1.40) .003 Diabetes 1.95 (1.69–2.25)  < .001 1.37 (1.18–1.61)  < .001 Hypertension 1.82 (1.59–2.07)  < .001 1.26 (1.08–1.46) .003 Poor self-rated health 1.33 (1.17–1.51)  < .001 1.15 (1.02–1.32) .027 Multi-morbidity 2.21 (1.95–2.51)  < .001 2.08 (1.83–2.37)  < .001 Vision impairment 1.82 (1.57–2.10)  < .001 1.73 (1.50–2.01)  < .001 Fear of falling 1.35 (1.14–1.59)  < .001 1.20 (1.01–1.43) .038 Falls in the previous year 1.31 (1.16–1.47)  < .001 1.14 (1.01–1.31) .050 Difficulties managing money 1.92 (1.44–2.56)  < .001 1.59 (1.16–2.08) .002 Difficulty shopping for groceries 2.01 (1.62–2.48)  < .001 1.57 (1.26–1.96)  < .001 Difficulty preparing meals 1.42 (1.15–1.74)  < .001 1.31 (1.06–1.63) .013 Difficulty taking transportation 1.32 (1.11–1.57)  < .001 1.06 (0.88–1.27) .537 Difficulty using the telephone 0.78 (0.63–0.97) .027 0.83 (0.66–1.03) .101 *Adjusted by sex, age, years of school, multi−morbidity, cognitive decline, and hearing impairment. OR odds ratio, SD standard deviation, f female Presence of glaucoma was significantly related to VI OR 1.73 (1.50–2.01), p < 0.001, impairment in instrumental activities in managing money OR 1.59 (1.16–2.08) p = 0.002, shopping for groceries OR 1.57 (CI 1.26–1.96) p < 0.001 and preparing meals OR 1.31 (1.06–1.63), p = 0.013; having had falls during the last year OR 1.14 (CI 1.01–1.31), p = 0.050, poor SRH OR 1.15 (CI 1.02–1.32), p = 0.027. (Table 2). Discussion The relationship between glaucoma and age has been well described [12, 25, 26]. Our findings are the first to expose the extend of the association in Colombia. The glaucoma group had a mean age 2 years higher. This could account for higher comorbidity and higher glaucoma risk, however when adjusting for multi-morbidity and other confounding factors, age remained statistically significant related to glaucoma report. As reported by other groups, our cohort had a higher glaucoma rate among women [6]. This might be explained by women’s increased longevity. Other series have failed to demonstrate a real gender predilection after statistical controls [27]. Although low oestrogen levels have been reported as a risk factor for optic nerve changes, its role in glaucoma is yet to be completely understood [28, 29]. Both HTN and DM had a significant association with glaucoma in our study. Research has showed up to 35% increased risk of developing open angle glaucoma in subjects with DM and 17% in HTN [27, 30]. Although DM and HTN are prevalent in old age, our data supports the notion that both entities have an independent effect on glaucoma report. Several authors have speculated that changes in systemic blood pressure may contribute to dysregulation of the intraocular pressure [31, 32]. Sociodemographic factors appear to have a significant impact in glaucoma. People with self-report of glaucoma diagnosis have higher educational levels in our sample. Higher education increases health access opportunities, allowing subjects to larger health access with regular eye examinations, allowing for earlier diagnosis [33, 34]. Education is also important as an intervention for treatment adherence [35]. Glaucoma is one of the major causes of irreversible vision loss worldwide [20], with a large impact on QoL [10], we found subjects with glaucoma to be more likely to have poor SRH. Glaucoma generates a significant VI with impairment for carrying out daily tasks such as walking outside, reading, seeing at night, adapting to lightning, and tasks that need discrimination of depths and distances [36–38]. This has been related to poor performance in different visual tasks (contrast sensitivity, dark adaptation, glare disability, and visual field tests) [39]. Based on this, VI has a negative impact on physical and mental health [36]. Previous reports have shown an increased risk of falling and having accidents, social isolation, and depression in glaucoma patients [40, 41]. Our study did not show that the self-report of glaucoma associated with depressive symptoms. We also found glaucoma to be related to fear of falling, after adjusting for falls during the previous year, as reported by other groups [42]. Managing money, shopping for groceries, and preparing meals were also affected in the glaucoma group. Previous research has shown evidence for decline in activities of daily living, and decreased QoL in glaucoma patients compared with controls, even at early stages, QoL decreases as glaucoma severity advances [43–46]. Vision loss in glaucoma can affect activities such as walking, venturing out from home, reading, seeing at night, adjusting to different levels of illumination, judging distances, driving, and seeing objects coming from the side with difficulties with central, near vision tasks, and reading the most often compromised [36, 37, 39]. Glaucoma is a condition of great concern that requires strategies for early detection, still underdiagnosed, with social factors like education and health access determining adequate diagnosis that in the long-term can improve functionality in the older adults, reduce risk of falling, overall morbidity, and mortality, and improve QoL for older adults. Latin America is living longer, and age is one of the most important risk factors for Glaucoma [30]. Our findings show a higher self-reported prevalence of glaucoma in the Colombian population, than earlier reported rates [23]. This may be explained by the older age of the cohort. The present study presents several limitations. The cross-sectional survey design does not allow to confirm causality between the studied factors and glaucoma. We did not have access to medical records that could allow for verifying reports. Likewise, most of the variables are self-reported, which may lead to numbers different to the actual ones, as is the diagnosis of glaucoma. To address these biases, we limited our data to those participants without cognitive decline [24]. Other studies highlight participants may underestimate or overestimate their conditions and visual abilities [47]. In this sense, self-report may be influenced by the frequency the person assists to doctor visits. This may not only affect the reported prevalence of glaucoma, but also other conditions, and be associated to the positive relation with socioeconomic status and health access. However, we used a significant and representative sample and adjusted for possible confounding variables and found various significant associations that may contribute to the approach of the disease in the clinical and public health context. Although prevalence estimates have been given in Latin America and Colombia, it is important to further explore factors related to glaucoma in other age groups. With glaucoma being a preventable and treatable disease with serious outcomes, our study is one of the few exploring the self-reported prevalence and associated factors to glaucoma in Colombian older adults. Appropriate glaucoma diagnosis must be followed by an adequate treatment with the goal of delaying disease progression and providing long-term visual function and QoL at a reasonable cost, compliance to treatment will be paramount to prevent vision loss [48]. We show modifiable risks factors for glaucoma that need to be addressed to improve overall older adult health, aiming for better functional performance and QoL in those 60 and over, this paper reflects the need of research around visual health in Latin America hoping to improve medical attention and prevention of glaucoma. Funding Open access funding provided by University of Stavanger & Stavanger University Hospital. The database used in this study is part of a larger project funded by the Administrative Department of Science, Technology, and Innovation (Colciencias) and the Ministry of Health and Social Protection of Colombia (SABE Study 2015, ID No. 764). MINCIENCIA—Pontificia Universidad Javeriana funding RC No. 829 in 2018. Declarations Conflict of interest The authors have no relevant financial or non-financial interests to disclose. Ethical approval Before enrolling in the study and completing the first test, participants gave written informed consent (including authorization to utilize secondary data and blood samples). The SABE Colombia Study was carried with adherence to the guidelines of the Declaration of Helsinki, with corresponding ethics committee approvals. This study has approbation by the ethics committee of the Pontificia Universidad Javeriana. Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. ==== Refs References 1. Bongaarts J Human population growth and the demographic transition Philos Trans R Soc B Biol Sci 2009 364 2985 2990 10.1098/rstb.2009.0137 2. de Carvalho IA Epping-Jordan J Beard JR Integrated Care for Older People 2019 Cham Springer 185 195 3. World Health Organization (2007) Global initiative for the elimination of avoidable blindness 4. Dandona L Dandona R Revision of visual impairment definitions in the international statistical classification of disease BMC Med 2006 4 7 10.1186/1741-7015-4-7 16539739 5. Leasher JL Braithwaite T Furtado JM Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: Magnitude, temporal trends and projections Br J Ophthalmol 2019 103 885 893 10.1136/bjophthalmol-2017-311746 30209083 6. Rojas CL Rey SB Dávila Ramírez F Responsable A Prevalencia del Glaucoma y su Contribución a la Discapacidad Visual en Colombia glaucoma prevalence and its contribution to visual impairment in Colombia 1 Rev Sociedad Colombiana de Oftalmología 2015 48 175 181 7. Bourne RRA Flaxman SR Braithwaite T Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis Lancet Glob Health 2017 5 e888 e897 10.1016/S2214-109X(17)30293-0 28779882 8. Lee DJ, Arheart KL, Lam BL et al (2009) Trends in reported visual impairment in United States adults. 16:42–49. 10.1080/09286580802624434 9. (2016) Making Eye Health a Population Health Imperative. National Academies Press 10. Varma R Lee PP Goldberg I Kotak S An assessment of the health and economic burdens of glaucoma Am J Ophthalmol 2011 152 515 522 10.1016/j.ajo.2011.06.004 21961848 11. Wong R Peláez M Palloni A Autoinforme de salud general en adultos mayores de América Latina y el Caribe: Su utilidad como indicador Revista Panamericana de Salud Publica/Pan American Journal of Public Health 2005 17 323 332 10.1590/s1020-49892005000500004 16053642 12. Weinreb RN Aung T Medeiros FA The pathophysiology and treatment of glaucoma: a review JAMA J Am Med Assoc 2014 311 1901 1911 10.1001/jama.2014.3192 13. Bahrami H (2009) Causal models in primary open angle glaucoma. 13:291–298. 10.1080/09286580600803677 14. Iwase A, Suzuki Y, Araie M (2014) Characteristics of undiagnosed primary open-angle glaucoma: The Tajimi Study. 21:39–44. 10.3109/09286586.2013.867510 15. Leske MC (2007) Open-angle glaucoma—AN epidemiologic overview. In: Ophthalmic Epidemiology. Taylor & Francis, pp 166–172 16. Hashemi H Mohammadi M Zandvakil N Prevalence and risk factors of glaucoma in an adult population from Shahroud Iran J Current Ophthalmol 2019 31 366 372 10.1016/j.joco.2018.05.003 17. Rao VR Stubbs EBJ TGF-β2 promotes oxidative stress in human trabecular meshwork cells by selectively enhancing NADPH oxidase 4 expression Invest Ophthalmol Vis Sci 2021 62 4 10.1167/iovs.62.4.4 33821883 18. Andrade JCF Kanadani FN Furlanetto RL Elucidation of the role of the lamina cribrosa in glaucoma using optical coherence tomography Surv Ophthalmol 2021 10.1016/j.survophthal.2021.01.015 33548238 19. Quaranta L Bruttini C Micheletti E Glaucoma and neuroinflammation: an overview Surv Ophthalmol 2021 10.1016/j.survophthal.2021.02.003 33582161 20. Tham YC Li X Wong TY Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis Ophthalmology 2014 121 2081 2090 10.1016/j.ophtha.2014.05.013 24974815 21. Galvis V (2009) Prevalencia de ceguera en el departamento de Santander—Colombia 22. Pascolini D Mariotti SP Global estimates of visual impairment: 2010 Br J Ophthalmol 2012 96 614 618 10.1136/bjophthalmol-2011-300539 22133988 23. Ministerio de Salud y Protección Social (2014) Análisis de Situación de Salud Visual en Colombia 2016. Bogotá 24. Gomez F, Corchuelo J, Curcio CL et al (2016) SABE Colombia: survey on health, well-being, and aging in colombia—study design and protocol. Current Gerontol Geriatrics Res 2016. 10.1155/2016/7910205 25. Amarís P, Arenas E, Belalcázar S et al (2008) Guías de Práctica Clínica Sociedad Colombiana de Oftalmología. SOCOFTAL, pp 9–56 26. Quigley HA West SK Rodriguez J The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER Arch Ophthalmol 2001 119 1819 1826 10.1001/archopht.119.12.1819 11735794 27. Mcmonnies CW Glaucoma history and risk factors J Optometry 2017 10 71 78 10.1016/j.optom.2016.02.003 28. Giordano C Montopoli M Perli E Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy Brain 2011 134 220 234 10.1093/brain/awq276 20943885 29. Vajaranant TS Nayak S Wilensky JT Joslin CE Gender and glaucoma: what we know and what we need to know Curr Opin Ophthalmol 2010 21 91 99 10.1097/ICU.0b013e3283360b7e 20051857 30. Furtado JM Lansingh VC Carter MJ Causes of blindness and visual impairment in latin america Surv Ophthalmol 2012 57 149 177 10.1016/j.survophthal.2011.07.002 22137039 31. Yilmaz KC Sur Gungor S Ciftci O Relationship between primary open angle glaucoma and blood pressure Acta Cardiol 2020 75 54 58 10.1080/00015385.2018.1549004 30650042 32. Lee JWY Chan PP Zhang XJ Latest developments in normal-pressure glaucoma: diagnosis, epidemiology, genetics, etiology, causes and mechanisms to management Asia-Pacific Journal of Ophthalmology 2019 8 457 468 10.1097/01.APO.0000605096.48529.9c 31789648 33. Oh SA Ra H Jee D Socioeconomic status and glaucoma: associations in high levels of income and education Curr Eye Res 2019 44 436 441 10.1080/02713683.2018.1548129 30433828 34. van Doorslaer E, Masseria C, Koolman X (2006) Inequalities in access to medical care by income in developed countries. CMAJ Canad Med Assoc J 174:177–183. 10.1503/cmaj.050584 35. Djafari F, Lesk MR, Giguère CÉ et al (2015) Impact of a brief educational intervention on glaucoma persistence: a randomized controlled clinical trial 22:380–386. 10.3109/09286586.2015.1083036 36. Quaranta L Riva I Gerardi C Quality of life in glaucoma: a review of the literature Adv Ther 2016 33 959 981 10.1007/s12325-016-0333-6 27138604 37. Ramulu PY Maul E Hochberg C Real-world assessment of physical activity in glaucoma using an accelerometer Ophthalmology 2012 119 1159 1166 10.1016/j.ophtha.2012.01.013 22386950 38. Ramulu P Glaucoma and disability: Which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol 2009 20 92 98 10.1097/ICU.0b013e32832401a9 19240541 39. Nelson P Aspinall P Papasouliotis O Quality of life in glaucoma and its relationship with visual function J Glaucoma 2003 12 139 150 10.1097/00061198-200304000-00009 12671469 40. Ivers RQ Cumming RG Mitchell P Attebo K Visual impairment and falls in older adults: the blue mountains eye study J Am Geriatr Soc 1998 46 58 64 10.1111/j.1532-5415.1998.tb01014.x 9434666 41. McGwin G Xie A Mays A Visual field defects and the risk of motor vehicle collisions among patients with glaucoma Invest Ophthalmol Vis Sci 2005 46 4437 4441 10.1167/iovs.05-0750 16303931 42. Ramulu PY Van Landingham SW Massof RW Fear of falling and visual field loss from glaucoma Ophthalmology 2012 119 1352 1358 10.1016/j.ophtha.2012.01.037 22480738 43. Hyman LG Komaroff E Heijl A Treatment and vision-related quality of life in the early manifest glaucoma trial Ophthalmology 2005 112 1505 1513 10.1016/j.ophtha.2005.03.028 16019074 44. Ekici F Loh R Waisbourd M Relationships between measures of the ability to perform vision-related activities, vision-related quality of life, and clinical findings in patients with glaucoma JAMA Ophthalmology 2015 133 1377 1385 10.1001/jamaophthalmol.2015.3426 26425961 45. Azoulay-Sebban L Zhao Z Zenouda A Correlations between subjective evaluation of quality of life, visual field loss, and performance in simulated activities of daily living in glaucoma patients J Glaucoma 2020 29 970 974 10.1097/IJG.0000000000001597 32649451 46. Bekibele CO, Gureje O (2009) Self-reported visual impairment and impact on vision-related activities in an elderly nigerian population: report from the ibadan study of ageing 15:250–256. 10.1080/09286580802336583 47. Skalicky SE Lamoureux EL Crabb DP Ramulu PY Patient-reported outcomes, functional assessment, and utility values in glaucoma J Glaucoma 2019 28 89 96 10.1097/IJG.0000000000001155 30540677 48. Topouzis F, Anastasopoulos E (2007) Glaucoma—the importance of early detection and early treatment. Eur Ophthal Rev 13. 10.17925/EOR.2007.00.00.13